• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo

tetano

Editor, Senior Moderator
Vaccine. 2013 Feb 1. pii: S0264-410X(13)00105-9. doi: 10.1016/j.vaccine.2013.01.037. [Epub ahead of print]
Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo.
Garulli B, Di Mario G, Sciaraffia E, Accapezzato D, Barnaba V, Castrucci MR.
Source

Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanit?, 00161 Rome, Italy; Department of Biology and Biotechnology "Charles Darwin", University of Rome "La Sapienza", 00185 Rome, Italy.
Abstract

Current influenza vaccines induce poor cross-reactive CD8+ T cell responses. Cellular immunity is generally specific for epitopes that are remarkably conserved among different subtypes, suggesting that strategies to improve the cross-presentation of viral antigens by dendritic cells (DC) could elicit a broadly protective immune response. Previous studies have shown that limited proteolysis within the endocytic pathway can favorably influence antigen processing and thus immune responses. Herein, we demonstrate that chloroquine improves the cross-presentation of non-replicating influenza virus in vitro and T cell responses in mice following a single administration of inactivated HI-X31 virus. CD8+ T cells were also recruited to lymph nodes draining the site of infection and able to reduce viral load following pulmonary challenge with the heterologous PR8 virus. These findings may have implications for vaccination strategies aimed at improving the cross-presentation capacity of DCs and thus the size of effector and memory CD8+ T cells against influenza vaccines.

Copyright ? 2013 Elsevier Ltd. All rights reserved.

PMID:
23380456
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23380456
 
Back
Top Bottom